FI76337C - Foerfarande foer framstaellning av nya, farmakologiskt aktiva 4,7-dihydropyrazolo/3,4-b/pyridin-5- karboxylsyraderivat. - Google Patents

Foerfarande foer framstaellning av nya, farmakologiskt aktiva 4,7-dihydropyrazolo/3,4-b/pyridin-5- karboxylsyraderivat. Download PDF

Info

Publication number
FI76337C
FI76337C FI834661A FI834661A FI76337C FI 76337 C FI76337 C FI 76337C FI 834661 A FI834661 A FI 834661A FI 834661 A FI834661 A FI 834661A FI 76337 C FI76337 C FI 76337C
Authority
FI
Finland
Prior art keywords
methyl
alkyl
pyridine
carboxylic acid
phenyl
Prior art date
Application number
FI834661A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI76337B (fi
FI834661A7 (fi
FI834661A0 (fi
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of FI834661A0 publication Critical patent/FI834661A0/fi
Publication of FI834661A7 publication Critical patent/FI834661A7/fi
Publication of FI76337B publication Critical patent/FI76337B/fi
Application granted granted Critical
Publication of FI76337C publication Critical patent/FI76337C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI834661A 1982-12-20 1983-12-19 Foerfarande foer framstaellning av nya, farmakologiskt aktiva 4,7-dihydropyrazolo/3,4-b/pyridin-5- karboxylsyraderivat. FI76337C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8236131 1982-12-20
GB8236131 1982-12-20

Publications (4)

Publication Number Publication Date
FI834661A0 FI834661A0 (fi) 1983-12-19
FI834661A7 FI834661A7 (fi) 1984-06-21
FI76337B FI76337B (fi) 1988-06-30
FI76337C true FI76337C (fi) 1988-10-10

Family

ID=10535093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834661A FI76337C (fi) 1982-12-20 1983-12-19 Foerfarande foer framstaellning av nya, farmakologiskt aktiva 4,7-dihydropyrazolo/3,4-b/pyridin-5- karboxylsyraderivat.

Country Status (19)

Country Link
US (1) US4954508A (enEXAMPLES)
EP (1) EP0114273B1 (enEXAMPLES)
JP (1) JPH0660181B2 (enEXAMPLES)
KR (1) KR890002227B1 (enEXAMPLES)
AT (1) ATE69227T1 (enEXAMPLES)
AU (1) AU574654B2 (enEXAMPLES)
DE (1) DE3382452D1 (enEXAMPLES)
DK (1) DK582083A (enEXAMPLES)
ES (2) ES8601987A1 (enEXAMPLES)
FI (1) FI76337C (enEXAMPLES)
GR (1) GR79111B (enEXAMPLES)
IE (1) IE57305B1 (enEXAMPLES)
IL (1) IL70445A (enEXAMPLES)
MY (1) MY101250A (enEXAMPLES)
NO (1) NO160367C (enEXAMPLES)
NZ (1) NZ206626A (enEXAMPLES)
PH (1) PH20896A (enEXAMPLES)
PT (1) PT77850B (enEXAMPLES)
ZA (1) ZA839092B (enEXAMPLES)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
US4916140A (en) * 1988-09-28 1990-04-10 Merrell Dow Pharmaceuticals Inc. Antiepileptic pyrazolopyridines
KR20030076650A (ko) * 2001-02-02 2003-09-26 미쯔비시 웰 파마 가부시키가이샤 디하이드로피라졸로피리딘 화합물 및 그의 약학적 용도
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
CN1823067A (zh) * 2003-06-13 2006-08-23 赞塔里斯有限公司 具有抑制磷脂酰肌醇3－激酶活性的化合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
DE2356684A1 (de) * 1972-11-15 1974-05-16 Heyden Chem Fab Neue 4-aminoderivate von pyrazolo (3,4-b)pyridin-5-carboxamiden
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
GB1568399A (en) * 1975-10-16 1980-05-29 Squibb & Sons Inc Pyrazolo pyridine derivatives
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
GR79111B (enEXAMPLES) 1984-10-02
DK582083A (da) 1984-06-21
ES528152A0 (es) 1985-11-16
EP0114273B1 (en) 1991-11-06
ES8506016A1 (es) 1985-06-16
NZ206626A (en) 1986-11-12
PH20896A (en) 1987-05-27
JPH0660181B2 (ja) 1994-08-10
EP0114273A1 (en) 1984-08-01
FI76337B (fi) 1988-06-30
PT77850A (en) 1984-01-01
MY101250A (en) 1991-08-17
KR840007000A (ko) 1984-12-04
NO834695L (no) 1984-06-21
ATE69227T1 (de) 1991-11-15
NO160367C (no) 1989-04-12
JPS59118786A (ja) 1984-07-09
US4954508A (en) 1990-09-04
DE3382452D1 (de) 1991-12-12
AU2227083A (en) 1984-06-28
IE832988L (en) 1984-06-20
ES8601987A1 (es) 1985-11-16
FI834661A7 (fi) 1984-06-21
NO160367B (no) 1989-01-02
PT77850B (en) 1986-05-08
IL70445A (en) 1988-12-30
ES532124A0 (es) 1985-06-16
FI834661A0 (fi) 1983-12-19
IE57305B1 (en) 1992-07-15
KR890002227B1 (ko) 1989-06-24
ZA839092B (en) 1984-07-25
IL70445A0 (en) 1984-03-30
AU574654B2 (en) 1988-07-14
DK582083D0 (da) 1983-12-16

Similar Documents

Publication Publication Date Title
EP0400583B1 (en) Imidazoquinoxalinones, their aza analogs and process for their preparation
JP6117999B2 (ja) テトラヒドロシクロペンタピロール誘導体およびその製造方法
US6316438B1 (en) Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
EP0429149B1 (en) Tricyclic pteridinones and a process for their preparation
US4670438A (en) Imidazo[4,5-c]pyridazine-3-ones, imidazo[4,5-d]pyridazine-4-ones, imidazo[4,]pyrazin-5-ones, purin-2-ones, purin-6-ones, and purin-2,6-diones useful as hypotensive or cardiotonic agents
FI76337C (fi) Foerfarande foer framstaellning av nya, farmakologiskt aktiva 4,7-dihydropyrazolo/3,4-b/pyridin-5- karboxylsyraderivat.
NO160444B (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
SU799658A3 (ru) Способ получени солей пири-диНилАМиНОАлКилОВыХ эфиРОВ
DE2845220A1 (de) Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
SK129799A3 (en) Tetrahydropyridine compounds, pharmaceutical composition containing them and their use
KR900006448B1 (ko) 디히드로피라졸로[3,4-b]피리딘 유도체의 제조방법
US5166344A (en) Process for the preparation of imidazoquinoxalinones
EP1252163B1 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
SK47894A3 (en) 2-amino-4-chinolyl-dihydropyridines, method of their production treatments containing thereof, method of their production, and using of these compounds
KR930001414B1 (ko) 아졸 유도체와 그의 약제학적으로 허용가능한 염
AU2021300294A1 (en) Methods and intermediates for preparing JAK inhibitors
EP0328700A1 (en) 4,7-Dihydropyrazolo(1,5-a)pyrimidine compound and pharmaceutical use thereof
US5854419A (en) Tricyclic pteridinones and a process for their preparation
AU612356B2 (en) New pharmacologically active pyrazolopyridines
US6025489A (en) Tricyclic pteridinones and a process for their preparation
US5527908A (en) Pyrazolothiazolopyrimidine derivatives
HU192728B (en) Process for producing 4-oxo-pyrido/2,3-d/pyrimidine derivatives and pharmaceutical compositions containing them
US5602252A (en) Tricyclic pteridinones and a process for their preparation
SK47794A3 (en) Chinolyl-dihydropyridinecarboxylic acid esters, method of their production, medicines containing these matters, method of their production and using of these compounds
WO2025079090A1 (en) Substituted 4-heteroatom-isoquinolone compounds, process of preparation and applications thereof

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: GRUPPO LEPETIT S.P.A.